Ignite Creation Date:
2024-05-06 @ 1:07 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03930719
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2019-04-23
Brief Title:
Post-stroke Delirium Screening
Sponsor:
University Medicine Greifswald
Organization:
University Medicine Greifswald
Study Overview
Official Title:
Evaluation of Delirium Screening Tools for the Detection of Post-stroke Delirium
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PSD Screen
Brief Summary:
For a long time delirium was considered a merely temporary dysfunction of the brain Today it is established that it is a brain disease associated with network dysfunction neuroinflammation and impaired transmitter homeostasis in a multicausal model Following an episode of delirium many patients do not return to their prior level of cognitive and functional performance In particular failed or delayed diagnosis with consecutive inadequate therapy contribute to the development of long-term cognitive decline that may ultimately lead to long-term care Stroke patients are a particularly common delirium-affected population 10-46 depending on severity Despite the frequency and clinical relevance of delirium in stroke patients diagnostic characteristics of common screening methods are unknown Similarly the clinical phenotype and risk factors of patients who develop delirium have not been adequately described
This study primarily aims to evaluate the diagnostic properties of established screening tools for delirium in a prospective cohort of well-characterised patients following ischemic cerebral events either transient or manifest stroke Secondary outcome criteria include predictors of post-stroke delirium PSD such as stroke location and size pre-stroke cognitive functioning ability to participate in daily routine activities and medical conditions
This study primarily aims to evaluate the diagnostic properties of established screening tools for delirium in a prospective cohort of well-characterised patients following ischemic cerebral events either transient or manifest stroke Secondary outcome criteria include predictors of post-stroke delirium PSD such as stroke location and size pre-stroke cognitive functioning ability to participate in daily routine activities and medical conditions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None